Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC.MRVI · Entity 4291 | See Remarks | March 17, 2025 | March 19, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MARAVAI LIFESCIENCES HOLDINGS, INC.
Report date March 17, 2025 · Filed March 19, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 606,791 |
Reported balance
After 2025-03-17 transaction · row 1
1 source rowRow 1 · 2025-03-17 · Grant · Acquired 295,858 · Balance 606,791 F1: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in 1/3rd increments on each of March 15, 2026, March 15, 2027, and March 15, 2028, subject to the Reporting Person's continued employment with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in 1/3rd increments on each of March 15, 2026, March 15, 2027, and March 15, 2028, subject to the Reporting Person's continued employment with the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 17, 2025 Filed Mar 19, 2025 21:58 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 295,858 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001823239-25-000054 · wk-form4_1742421483.xml · nonDerivative · entry 1 BUZZEO REBECCA · CIK 0001970970 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 606,791 F1 · price: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in 1/3rd increments on each of March 15, 2026, March 15, 2027, and March 15, 2028, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 21:26 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Tax withholdingClass A Common Stock | 4,314 | $2.64 | $11,388.96 |
DisclosureSEC source: 0001823239-25-000040 · wk-form4_1742419582.xml · nonDerivative · entry 1 BUZZEO REBECCA · CIK 0001970970 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,933 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:18 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Tax withholdingClass A Common Stock | 45,456 | $4.56 | $207,279.36 |
DisclosureSEC source: 0001823239-25-000013 · wk-form4_1737148728.xml · nonDerivative · entry 1 BUZZEO REBECCA · CIK 0001970970 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,247 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 21:32 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Tax withholdingClass A Common Stock | 4,363 | $4.42 | $19,284.46 |
DisclosureSEC source: 0001823239-24-000122 · wk-form4_1731965544.xml · nonDerivative · entry 1 BUZZEO REBECCA · CIK 0001970970 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360,703 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 22:00 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Tax withholdingClass A Common Stock | 4,366 | $7.70 | $33,618.20 |
DisclosureSEC source: 0001823239-24-000044 · wk-form4_1710799246.xml · nonDerivative · entry 1 BUZZEO REBECCA · CIK 0001970970 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,066 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:20 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 288,198 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001823239-24-000004 · wk-form4_1705620001.xml · nonDerivative · entry 1 BUZZEO REBECCA · CIK 0001970970 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369,432 F1 · price: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in one-half (1/2) increments on each of January 15, 2025, and January 15, 2026, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 22:21 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Tax withholdingClass A Common Stock | 4,549 | $5.19 | $23,609.31 |
DisclosureSEC source: 0001823239-23-000094 · wk-form4_1700173279.xml · nonDerivative · entry 1 BUZZEO REBECCA · CIK 0001970970 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,234 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.